ESTRADIOL 3-GLUCURONIDE IS TRANSPORTED BY THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 BUT DOES NOT ACTIVATE THE ALLOSTERIC SITE BOUND BY ESTRADIOL 17-GLUCURONIDE

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Drug Metabolism And Disposition

• Publication date

  2004-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/dmd.104.000372PMID 15280218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transport of Ethinylestradiol Glucuronide and Ethinylestradiol Sulfate by the Multidrug Resistance Proteins MRP1, MRP2, and MRP3

  2004influential reference
• Biliary Secretion of Glutathione in Estradiol 17β-d-Glucuronide-Induced Cholestasis

  2003cited by this paper
• Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10).

  2003influential reference
• Differential Modulation of the Human Liver Conjugate Transporters MRP2 and MRP3 by Bile Acids and Organic Anions*

  2003cited by this paper
• Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435].

  2003cited by this paper
• The superfamily of organic anion transporting polypeptides.

  2003cited by this paper
• Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).

  2003influential reference
• Allosteric Modulation of Human P-glycoprotein

  2003cited by this paper
• 459 Effects of human MRP2 mutations on its transport and ATPase activities and activation by ursodiol

  2003cited by this paper
• Estradiol-17beta-D-glucuronide induces endocytic internalization of Bsep in rats.

  2003cited by this paper
• ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics*

  2003cited by this paper
• Evidence for Two Interacting Ligand Binding Sites in Human Multidrug Resistance Protein 2 (ATP Binding Cassette C2)*

  2003influential reference
• Regulation of Expression of the Multidrug Resistance-Associated Protein 2 (MRP2) and Its Role in Drug Disposition

  2002cited by this paper
• Mrp2 modulates the activity of chloride channels in isolated hepatocytes

  2002cited by this paper
• Altered localization and activity of canalicular Mrp2 in estradiol‐17β‐D‐glucuronide–induced cholestasis

  2002cited by this paper
• Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6).

  2002cited by this paper
• Reconstitution of Transport-Active Multidrug Resistance Protein 2 (MRP2; ABCC2) in Proteoliposomes

  2002cited by this paper
• Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity.

  2001influential reference
• Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site.

  2001cited by this paper
• Charged amino acids in the transmembrane domains are involved in the determination of the substrate specificity of rat Mrp2.

  2001influential reference
• Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate.

  2001influential reference
• Mrp2 is essential for estradiol-17beta(beta-D-glucuronide)-induced cholestasis in rats.

  2000cited by this paper
• Short-Term Regulation of Canalicular Transport

  2000cited by this paper
• Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export

  2000cited by this paper
• Mrp2 is essential for estradiol‐17β(β‐D ‐glucuronide)–induced cholestasis in rats

  2000cited by this paper
• Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3)*

  1999cited by this paper
• Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells.

  1999cited by this paper
• Adenosine triphosphate–dependent transport of estradiol‐17β(β‐d‐glucuronide) in membrane vesicles by MDR1 expressed in insect cells

  1998influential reference
• Adenosine triphosphate-dependent transport of estradiol-17beta(beta-D-glucuronide) in membrane vesicles by MDR1 expressed in insect cells.

  1998influential reference
• Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2.

  1997influential reference
• Biliary excretion of estradiol‐17β‐glucuronide in the rat

  1996influential reference
• Biliary excretion of estradiol-17 beta-glucuronide in the rat.

  1996influential reference
• ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids.

  1996influential reference
• Estradiol 17 beta-D-glucuronide is a high-affinity substrate for oatp organic anion transporter.

  1996influential reference
• ATP-dependent transport of beta-estradiol 17-(beta-D-glucuronide) in rat canalicular membrane vesicles.

  1996cited by this paper
• ATP-dependent 17-Estradiol 17-(-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP)

  1996influential reference
• Characterizing mechanisms of hepatic bile acid transport utilizing isolated membrane vesicles.

  1990cited by this paper
• Intermediary metabolism of estriol in pregnancy.

  1984cited by this paper
• Steroid D-ring glucuronides: characterization of a new class of cholestatic agents in the rat.

  1981cited by this paper
• Characterization of cholestasis induced by estradiol-17 beta-D-glucuronide in the rat.

  1980influential reference
• Determination of estrogen ring D glucuronides in pregnancy plasma by direct radioimmunoassay without hydrolysis.

  1979cited by this paper
• Estrogens in pregnancy.

  1977cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Evaluation of potential substrates and inhibitors of MRP2 transporter to predict effective combinatorial chemotherapeutic agents for treating MRP2-associated non-responsive colorectal cancer

  2025cites this paper
• The next frontier in ADME science: Predicting transporter-based drug disposition, tissue concentrations and drug-drug interactions in humans.

  2022cites this paper
• Hepatic Bile Formation: Canalicular Osmolarity and Paracellular and Transcellular Water Flow

  2019influential citation
• Drug Concentration Asymmetry in Tissues and Plasma for Small Molecule–Related Therapeutic Modalities

  2019cites this paper
• MRP2 Inhibition by HIV Protease Inhibitors in Rat and Human Hepatocytes: A Quantitative Confocal Microscopy Study

  2018cites this paper
• substrate transport upon cooperative estradiol-17-ß-D-3 glucuronide binding in a Drosophila ABCC transporter 4 5 Short title : 6 Increased coupling by cooperative substrate binding in Drosophila ABCC

  2018cites this paper
• Pharmacokinetics , Pharmacodynamics and Drug Transport and Metabolism Cellular PharmacokineticModel-BasedAnalysis ofGenistein , Glyceollin , and MK-571 Effects on 5 ( and 6 )-Carboxy-2 0 , 7 0-Dichloro fl ourescein Disposition in Caco-2 Cells

  2018cites this paper
• Boosted coupling of ATP hydrolysis to substrate transport upon cooperative estradiol‐17‐β‐D‐glucuronide binding in a Drosophila ATP binding cassette type‐C transporter

  2017cites this paper
• Hepatic Transporter Function in Liver Disease: Impact on Hepatobiliary Disposition and Pharmacokinetics

  2017cites this paper
• Cellular Pharmacokinetic Model-Based Analysis of Genistein, Glyceollin, and MK-571 Effects on 5 (and 6)-Carboxy-2',7'-Dichloroflourescein Disposition in Caco-2 Cells.

  2017cites this paper
• Cysteinyl Leukotriene Receptor 1/2 Antagonists Nonselectively Modulate Organic Anion Transport by Multidrug Resistance Proteins (MRP1-4)

  2016cites this paper
• A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

  2013cites this paper
• Application of quantitative time-lapse imaging (QTLI) for evaluation of Mrp2-based drug-drug interaction induced by liver metabolites.

  2012cites this paper
• Quantitative immunofluorescent blotting of the multidrug resistance-associated protein 2 (MRP2).

  2011cites this paper
• Functional analysis of nonsynonymous single nucleotide polymorphisms of multidrug resistance-associated protein 2 (ABCC2)

  2011cites this paper
• Modulators of multidrug resistance associated proteins in the management of anticancer and antimicrobial drug resistance and the treatment of inflammatory diseases.

  2010cites this paper
• Hepatobiliary Disposition of 3α,6α,7α,12α-Tetrahydroxy-Cholanoyl Taurine: A Substrate for Multiple Canalicular Transporters

  2010cites this paper
• ABCC2/Abcc2: a multispecific transporter with dominant excretory functions

  2010cites this paper
• Multidrug Resistance Protein 2-Mediated Estradiol-17β-d-glucuronide Transport Potentiation: In Vitro-in Vivo Correlation and Species Specificity

  2009cites this paper
• Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments.

  2009cites this paper
• Transport of Diclofenac by Breast Cancer Resistance Protein (ABCG2) and Stimulation of Multidrug Resistance Protein 2 (ABCC2)-Mediated Drug Transport by Diclofenac and Benzbromarone

  2009cites this paper
• Potentiation of MRP2/Mrp2‐Mediated Estradiol‐17β‐Glucuronide Transport by Drugs – A Concise Review

  2009cites this paper
• Pharmacological functions of multidrug transporters: studies employing combination transporter knockout mice

  2009cites this paper
• Species-Dependent Transport and Modulation Properties of Human and Mouse Multidrug Resistance Protein 2 (MRP2/Mrp2, ABCC2/Abcc2)

  2008cites this paper
• Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.

  2008cites this paper
• In Silico Models for Interactions with Transporters

  2007cites this paper
• Human Multidrug Resistance Protein 2 Transports the Therapeutic Bile Salt Tauroursodeoxycholate

  2007cites this paper
• MRP2 and 3 in health and disease.

  2006cites this paper
• Lack of interaction between tauroursodeoxycholate and ATP-binding cassette transporter isoform G2 (ABCG2).

  2006cites this paper
• Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites.

  2006cites this paper
• Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL/6 mice

  2006cites this paper
• Increase in Mrp 1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C 57 BL / 6 mice

  2006cites this paper
• Human Multidrug Resistance Protein 2 (MRP2/ABCC2) Transports the Therapeutic Bile Salt Tauroursodeoxycholate

  2006influential citation
• Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport.

  2006cites this paper
• Functional Analysis of Mouse and Monkey Multidrug Resistance-Associated Protein 2 (Mrp2)

  2006influential citation
• Mini-review MRP 2 and 3 in health and disease

  2006cites this paper
• VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION

  2005cites this paper